Abaloparatide increases bone mass without affecting growth of bone-disseminated cancer cells is a research paper published in JBMR Plus (2025). On theSindex it has a DataRank of 0. It has been cited 4 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
DoD Breakthrough Award
Grant: W81XWH-18-1-0029
National Institutes of Health
Grant: 3P30CA068485-23S2
Cancer Center Support Grant
NCI NIH HHS
Grant: P30 CA068485
FWCI
1.91
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords